Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.6 SEK | -4.12% | 0.00% | +11.71% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 421.3 | 501.8 | 351.9 | 547.7 | 179.7 | 103.2 |
Enterprise Value (EV) 1 | 409.5 | 501 | 343 | 560.2 | 217.3 | 116 |
P/E ratio | 15.9 x | 17.9 x | 19.8 x | 25.7 x | -63.6 x | -16.7 x |
Yield | 2.21% | 2.16% | 2.64% | 1.41% | - | - |
Capitalization / Revenue | 1.07 x | 1.11 x | 0.78 x | 1.06 x | 0.37 x | 0.19 x |
EV / Revenue | 1.04 x | 1.11 x | 0.76 x | 1.09 x | 0.45 x | 0.22 x |
EV / EBITDA | 11.7 x | 13.6 x | 14 x | 19.1 x | -59.1 x | -59.7 x |
EV / FCF | 36.4 x | -48.2 x | 19.2 x | -33.8 x | -13 x | 3.86 x |
FCF Yield | 2.75% | -2.07% | 5.2% | -2.95% | -7.67% | 25.9% |
Price to Book | 5.25 x | 4.92 x | 3.36 x | 4.55 x | 1.6 x | 0.97 x |
Nbr of stocks (in thousands) | 6,195 | 6,195 | 6,195 | 6,195 | 6,195 | 6,195 |
Reference price 2 | 68.00 | 81.00 | 56.80 | 88.40 | 29.00 | 16.65 |
Announcement Date | 19-03-28 | 20-03-27 | 21-03-26 | 22-03-25 | 23-03-27 | 24-03-28 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 393.7 | 452.6 | 450.1 | 514.8 | 487.5 | 533.8 |
EBITDA 1 | 34.86 | 36.86 | 24.46 | 29.34 | -3.68 | -1.944 |
EBIT 1 | 34.22 | 36.3 | 23.84 | 28.55 | -4.749 | -3.166 |
Operating Margin | 8.69% | 8.02% | 5.3% | 5.54% | -0.97% | -0.59% |
Earnings before Tax (EBT) 1 | 34.12 | 36.07 | 23.29 | 27.96 | -5.166 | -5.914 |
Net income 1 | 26.52 | 28.07 | 17.76 | 21.3 | -2.823 | -6.194 |
Net margin | 6.74% | 6.2% | 3.95% | 4.14% | -0.58% | -1.16% |
EPS 2 | 4.281 | 4.532 | 2.868 | 3.439 | -0.4557 | -0.9998 |
Free Cash Flow 1 | 11.26 | -10.39 | 17.84 | -16.55 | -16.66 | 30.01 |
FCF margin | 2.86% | -2.3% | 3.96% | -3.22% | -3.42% | 5.62% |
FCF Conversion (EBITDA) | 32.3% | - | 72.93% | - | - | - |
FCF Conversion (Net income) | 42.45% | - | 100.44% | - | - | - |
Dividend per Share 2 | 1.500 | 1.750 | 1.500 | 1.250 | - | - |
Announcement Date | 19-03-28 | 20-03-27 | 21-03-26 | 22-03-25 | 23-03-27 | 24-03-28 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | 12.5 | 37.6 | 12.8 |
Net Cash position 1 | 11.7 | 0.85 | 8.84 | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | 0.4275 x | -10.23 x | -6.599 x |
Free Cash Flow 1 | 11.3 | -10.4 | 17.8 | -16.6 | -16.7 | 30 |
ROE (net income / shareholders' equity) | 37.6% | 30.8% | 17.2% | 18.9% | -2.42% | -5.67% |
ROA (Net income/ Total Assets) | 14.2% | 12.6% | 7.67% | 8.3% | -1.21% | -0.79% |
Assets 1 | 186.9 | 222.6 | 231.7 | 256.6 | 233 | 783.8 |
Book Value Per Share 2 | 12.90 | 16.50 | 16.90 | 19.40 | 18.20 | 17.10 |
Cash Flow per Share 2 | 2.320 | 1.750 | 1.680 | 1.920 | 1.730 | 2.230 |
Capex 1 | 0.88 | 0.94 | 0.75 | 1.06 | 1.59 | 2.14 |
Capex / Sales | 0.22% | 0.21% | 0.17% | 0.2% | 0.33% | 0.4% |
Announcement Date | 19-03-28 | 20-03-27 | 21-03-26 | 22-03-25 | 23-03-27 | 24-03-28 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+11.71% | 11.11M | |
+19.40% | 8.71B | |
+8.05% | 7.81B | |
+7.42% | 6.69B | |
-6.43% | 3.78B | |
-6.64% | 3.77B | |
-3.06% | 1.41B | |
-26.57% | 1.13B | |
+20.86% | 1.07B | |
-11.40% | 906M |
- Stock Market
- Equities
- NNH Stock
- Financials New Nordic Healthbrands AB